A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder

Published:2021-02 Issue: Volume:43 Page:92-101
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Sherwood Brown E.,McArdle Meagan,Palka Jayme,Bice Collette,Ivleva Elena,Nakamura Alyson,McNutt Markey,Patel Zena,Holmes Traci,Tipton Shane

Funder

Stanley Medical Research Institute

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference51 articles.

1. Factors associated with treatment nonadherence among US bipolar disorder patients;Baldessarini;Hum. Psychopharmacol.,2008

2. The central 5-HT3 receptor in CNS disorders;Bloom;Neurochem. Res.,1998

3. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence;Brown;Alcohol. Clin. Exp. Res.,2009

4. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders;Brown;J. Clin. Psychiatry,2008

5. Drug abuse and bipolar disorder: comorbidity or misdiagnosis?;Brown;J. Affect. Disord.,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in females;Neurobiology of Stress;2024-05

2. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis;Addiction;2024-01-03

3. Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management;Current Neuropharmacology;2023-04

4. Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder;Revista de Psiquiatría y Salud Mental;2023-02

5. A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder;Alcoholism: Clinical and Experimental Research;2022-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3